THE FIP1L1-PDGFRA FUSION GENE IS PRESENT IN APPROXIMATELY 10 15% OF PATIENTS WITH HYPER EOSINOPHILIC SYNDROME WHO ARE SENSITIVE TO TREATMENT WITH THE TYROSINE KINASE INHIBITOR IMATINIB.
Why book with us?
Free and On Schedule Sample Collection
24/7 Service
Affordable
Quick and Accurate Reports
4 ML (2 ML MIN.) WHOLE BLOOD / BONE MARROW FROM 1 LAVENDER TOP (EDTA) TUBE. SHIP REFRIGERATED. DO NOT FREEZE. DULY FILLED GENOMICS CLINICAL INFORMATION REQUISITION FORM IS MANDATORY.
PCR
REPORT ON 15TH DAY EVENING 7PM
DULY FILLED GENOMICS CLINICAL INFORMATION REQUISITION FORM IS MANDATORY.